We are proud to announce a 100% vaccination rate of all providers and staff at PCC!

Open Trials at PCC

Available Clinical Trials at Pacific Cancer Care

Pacific Cancer Care is driven by a vision to be the leader for the treatment of cancer in the Monterey County. Our clinicians and investigators identify and conduct Phase I-IV treatment options that are new and innovative, and that will positively impact our patients. Below is a list of clinical trials currently available at Pacific Cancer Care.

For more information regarding clinical trial opportunities, please contact us at (831) 375-4105.

Breast Cancer
Protocol Number: MK3475-B49
Protocol Title: A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Pembrolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy for the Treatment of Chemotherapy-Candidate Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2-) Locally Recurrent Inoperable or Metastatic Breast Cancer (KEYNOTE-B49)

More information available at: https://clinicaltrials.gov/ct2/show/NCT04895358

CLL/SLL or Non-Hodgkin’s Lymphomas
Protocol Number: APTO-CG-806-01
Protocol Title: A Phase 1 a/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients with CLL/SLL or Non-Hodgkin’s Lymphomas

More information available at: https://www.clinicaltrials.gov/ct2/show/NCT03893682

Hematologic Malignancies
Protocol Number: MK-4280-003
Protocol Title: A Phase 1/Phase 2 Clinical Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies

More information available at: https://clinicaltrials.gov/ct2/show/NCT03598608

Ovarian Cancer
Protocol Number: MK-3475-B96
Protocol Title: A Phase 3, Randomized, Double-Blind Study of Pembrolizumab versus Placebo in Combination with Paclitaxel With or Without Bevacizumab for the Treatment of Platinum-resistant Recurrent Ovarian Cancer (KEYNOTE B-96/ ENGOT-ov65)

More information available at: https://www.clinicaltrials.gov/ct2/show/NCT05116189

Solid Tumors or Hematologic Malignancies
Protocol Number: CIAPM Study (Stanford)-59855
Protocol Title: Reducing Cancer Disparities Through Innovative Community-Academic Partnership to Advance Access and Delivery of Precision Medicine in Monterey County (Addressing the Latinx CANcer Care Equity (ALCANCE)

More info available at: https://clinicaltrials.gov/ct2/show/NCT04843332

 *For a full list of clinical trials across the U.S. please visit https://clinicaltrials.gov/. 

Through partnerships with organizations such as the Dana Farber Cancer Institute and Parker Institute for Cancer Immunotherapy, our patients rest assured knowing that a full complement of research and clinical resources are available to them, all synchronized and supervised by their Pacific Cancer Care team.